January 6, 2017
GHG wraps up ABC Pharmacy buy
Georgia Healthcare Group (GHG) has finished all the paperwork in connection with buying the fourth largest pharmaceutical retailer in Georgia, ABC Pharmacia (ABC).
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
January 6, 2017
India’s Natco cleared to sell generic version of Teva’s leukemia treatment Trenda in USA
Indian drugmaker Natco Pharma has gotten the approval from the U.S. regulator for generic version of Teva’s leukemia treatment Trenda (Bendamustine Hydrochloride powder for Injection).
January 6, 2017
INEOS Styrolution presents new materials at Pharmapack 2017
INEOS Styrolution, the global leader in styrenics, will present new product highlights and a range of new applications for the healthcare industry at Pharmapack 2017 in Paris (Paris Expo, Porte de Versailles).
January 5, 2017
Lilly mixes managers, reduces U.S. staff due to Solanezumab test fail
Eli Lilly begins new year with reorganizing its leadership structure to pursue better growth opportunities in the upcoming years. The Chief Executive Officer of Lilly, David A. Ricks, who’s new position is also one among the latest promotions, said that the changes made to pharmaceutical therapeutics and geographic business should simplify and maximize the company’s late-stage pipeline and new drugs, as well as to improve productivity.
January 5, 2017
BMS, Janssen to test cancer drug together
BMS and Janssen Biotech announced continuation of their work together through a new clinical research.
January 5, 2017
FDA focuses on false drugs promotions
The U.S. Food and Drug Administration (FDA) has said that it plans to take a better look on how drug-makers describe their products and to make them focus on better explaining what the drug exactly do, and how consumers and healthcare professionals (HCPs) can detect false promotions.
January 5, 2017
Ceylad kicks off THINK cancer trial in Belgium, blood taken from the first patient
Celyad has started on Thursday its Therapeutic Immunotherapy with NKR-2 (THINK) trial in Belgium with the first patient giving blood.
To remind, THINK trial is an open-label Phase Ib study to assess the safety and clinical activity of multiple administrations of autologous CAR-T NKR-2 cells in seven refractory cancers.
January 5, 2017
Valneva, Merck in new animal vaccines deal (U.S.&Canada)
Valneva has given Merck in United States and Canada rights to use its EB66 technology to research new veterinary vaccines.
January 5, 2017
Futura Medicals launches condom in Saudi Arabia, expects further distribution in MENA
Transdermal technology specialist Futura Medicalis has made an – at least to say – interesting step in Saudi Arabia, country…
January 5, 2017
OptiBiotix replaces Commercial Director
OptiBiotix Health is rearranging its directorial staff as it has changed its Commercial Director. Namely, Jim Laird will be substituted by Per Rehné to that directorial position.